Stadt Hamburg, Hamburg, Germany
QPS was founded in 1995. Today, the company is considered one of the top CROs in the world. QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. QPS provides quality services to pharmaceutical and biotechnology clients worldwide.
PARTEX Vision - Becoming the World’s largest AI powered Drug Assets Manager. - With power of AI at its core, Partex delivers faster, lower-cost healthcare innovations, validated by wet-lab and real-world evidence. - Our pioneering digital platform enables smarter decision-making throughout the entire value chain. I am supporting PARTEX and it's subsidiaries (cureteq, INNOPLEXUS, assay.works, Amrit, perpetualblock) by creating new business opportunites and finding new cooperation partners.
CRS was established in 2006 as a merger of three German Phase-I CROs having more than 40 years of experience in clinical pharmacology. As of today, CRS comprises 5 Clinical Pharmacology Units (CPUs) in Germany with a total bed capacity of 260 beds. This makes CRS to one of the leading European provider of Phase-I services, including standard PK/PD trial designs as well as special fields of expertise in a strictly standardised Phase-I environment. Besides the standard Early Phase studies in healthy volunteers, a substantial part of CRS's business is the conduct of patient driven trials as well as multicentre trials. Clients from various sectors of the healthcare industry (ranging from pharmaceutical & biotech to developers of medicinal products, nutritionals and cosmetics) profit from the comprehensive service portfolio offered by CRS. Comprehensive Service Portfolio Consultancy Project Management Clinical Conduct Monitoring Quality Assurance Clinical Trial Supply Management / QPs Laboratory / Bioanalytical Services by external partners Clinical Data Management Statistics Medical Writing As strategic account lead I am responsible for maintaining and growing the largest strategic account of CRS by conducting governance meetings, regular video conferences with the sponsor and by providing internal guidance and support to team.
Proven global expertise. Since 1975, ACM Global Laboratories has been a recognized leader in both medical diagnostic and global clinical trial testing services. With wholly owned facilities in New York, England, Shanghai China, Mumbai India and Singapore, we operate in more than 65 countries around the globe. Our full-time staff of laboratory experts performs more than 30 million tests annually, spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more. As business development director I was responsible to grow ACM's Business in the D A CH region, finding new clients and increasing the ACM brand awareness in this region.
Biomedical Systems (acquired by ERT) is a premier global provider of centralized diagnostic services. Founded in 1975, Biomedical Systems has grown to be a leading clinical trial provider to pharmaceutical, medical device, biotech, and contract research organizations (CROs). Our comprehensive clinical trial solutions include cardiac safety, pulmonary function, imaging, electronic clinical outcome assessment (eCOA), and scientific affairs. I supported the BMS (and after the acquisition by ERT) and the ERT business development team by maintaining and intensifying business opportunities with recurring clients while hunting for new clients in the D A CH region.